CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 83 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q3 2018. The put-call ratio across all filers is 2.06 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $32,740,000 | +4.5% | 343,544 | +0.1% | 0.01% | 0.0% |
| Q1 2019 | $31,326,000 | +20.2% | 343,304 | 0.0% | 0.01% | +14.3% |
| Q4 2018 | $26,060,000 | -5.1% | 343,304 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $27,464,000 | -68.8% | 343,304 | -55.9% | 0.01% | -66.7% |
| Q2 2017 | $87,982,000 | – | 777,914 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Maso Capital Partners Ltd | 627,111 | $74,068,000 | 20.20% |
| Athos Capital Ltd | 362,909 | $42,863,000 | 11.81% |
| PSquared Asset Management AG | 205,000 | $24,213,000 | 3.85% |
| York Capital Management Global Advisors, LLC | 302,675 | $35,749,000 | 3.52% |
| HHLR ADVISORS, LTD. | 2,962,076 | $349,851,000 | 2.78% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 534,180 | $63,092,000 | 2.58% |
| Pentwater Capital Management LP | 1,178,000 | $139,134,000 | 1.68% |
| Temasek Holdings (Private) Ltd | 1,240,000 | $146,456,000 | 0.63% |
| AQR Arbitrage LLC | 142,733 | $16,858,000 | 0.59% |
| FORT, L.P. | 9,761 | $1,153,000 | 0.34% |